{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:50:42Z","timestamp":1776167442611,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-04833-y","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:38:52Z","timestamp":1772789932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance patterns and carbapenemase gene distribution in pediatric Pseudomonas aeruginosa isolates: molecular and epidemiological insights from an Iranian referral center"],"prefix":"10.1186","volume":"26","author":[{"given":"Erfaneh","family":"Jafari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Pourakbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Asadi Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Azizian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Sotoudeh Anvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setareh","family":"Mamishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"4833_CR1","unstructured":"WHO. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance: World Health Organization; 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240093461"},{"key":"4833_CR2","unstructured":"CDC. Antimicrobial Resistance Threats in the United States, 2021\u20132022. . Centers for Disease Control and Prevention (U.S); 2024. https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/update-2022.html"},{"issue":"18","key":"4833_CR3","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds D, Kollef M. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs. 2021;81(18):2117\u201331. https:\/\/doi.org\/10.1007\/s40265-021-01635-6.","journal-title":"Drugs"},{"issue":"12","key":"4833_CR4","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/pathogens10121638","volume":"10","author":"KA Glen","year":"2021","unstructured":"Glen KA, Lamont IL. \u03b2-lactam resistance in Pseudomonas aeruginosa: current status, future prospects. Pathogens. 2021;10(12):1638. https:\/\/doi.org\/10.3390\/pathogens10121638.","journal-title":"Pathogens"},{"key":"4833_CR5","doi-asserted-by":"publisher","first-page":"665759","DOI":"10.3389\/fcimb.2021.665759","volume":"11","author":"RF Langendonk","year":"2021","unstructured":"Langendonk RF, Neill DR, Fothergill JL. The building blocks of antimicrobial resistance in Pseudomonas aeruginosa: implications for current resistance-breaking therapies. Front Cell Infect Microbiol. 2021;11:665759. https:\/\/doi.org\/10.3389\/fcimb.2021.665759.","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"4833_CR6","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1093\/jac\/dkad196","volume":"78","author":"CI Barker","year":"2023","unstructured":"Barker CI, Kipper K, Lonsdale DO, Wright K, Thompson G, Kim M, et al. The neonatal and paediatric pharmacokinetics of antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence. J Antimicrob Chemother. 2023;78(9):2148\u201361. https:\/\/doi.org\/10.1093\/jac\/dkad196.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4833_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pedneo.2023.03.012","volume":"65","author":"J Chen","year":"2024","unstructured":"Chen J, Huang H, Liu C, Fu Y-q. Risk factors for mortality in Pseudomonas aeruginosa bacteremia in children. Pediatr Neonatol. 2024;65(1):31\u20137. https:\/\/doi.org\/10.1016\/j.pedneo.2023.03.012.","journal-title":"Pediatr Neonatol"},{"issue":"11","key":"4833_CR8","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.3390\/jcm14113714","volume":"14","author":"M Richert-Przygo\u0144ska","year":"2025","unstructured":"Richert-Przygo\u0144ska M, Czy\u017cewski K, Zalas-Wi\u0119cek P, Gryniewicz-Kwiatkowska O, Gietka A, Ma\u0142as Z, et al. Clinical analysis of pseudomonas aeruginosa infections in children undergoing chemotherapy or hematopoietic cell transplantation: a multicenter nationwide study. J Clin Med. 2025;14(11):3714. https:\/\/doi.org\/10.3390\/jcm14113714.","journal-title":"J Clin Med"},{"issue":"3","key":"4833_CR9","doi-asserted-by":"publisher","first-page":"10.1128\/msphere","DOI":"10.1128\/mSphere.00202-21","volume":"6","author":"M Al-Orphaly","year":"2021","unstructured":"Al-Orphaly M, Hadi HA, Eltayeb FK, Al-Hail H, Samuel BG, Sultan AA, et al. Epidemiology of multidrug-resistant Pseudomonas aeruginosa in the Middle East and North Africa Region. mSphere. 2021;6(3):10.1128\/msphere. 00202-21. https:\/\/doi.org\/10.1128\/mSphere.00202-21.","journal-title":"mSphere"},{"key":"4833_CR10","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S298838","author":"SH Abdel-Rhman","year":"2021","unstructured":"Abdel-Rhman SH, Rizk DE. Comparative assessment of different PCR-based typing methods of Pseudomonas aeruginosa isolates. Infect Drug Resist. 2021. https:\/\/doi.org\/10.2147\/IDR.S298838.","journal-title":"Infect Drug Resist"},{"issue":"12","key":"4833_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/gels8120760","volume":"8","author":"T Bogiel","year":"2022","unstructured":"Bogiel T, Mikucka A, Kanarek P. Agarose gel electrophoresis-based RAPD-PCR\u2014an optimization of the conditions to rapidly detect similarity of the alert pathogens for the purpose of epidemiological studies. Gels. 2022;8(12):760. https:\/\/doi.org\/10.3390\/gels8120760.","journal-title":"Gels"},{"key":"4833_CR12","doi-asserted-by":"publisher","first-page":"1431154","DOI":"10.3389\/fmicb.2024.1431154","volume":"15","author":"X Xie","year":"2024","unstructured":"Xie X, Liu Z, Huang J, Wang X, Tian Y, Xu P, et al. Molecular epidemiology and carbapenem resistance mechanisms of Pseudomonas aeruginosa isolated from a hospital in Fujian, China. Front Microbiol. 2024;15:1431154. https:\/\/doi.org\/10.3389\/fmicb.2024.1431154.","journal-title":"Front Microbiol"},{"key":"4833_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07967","author":"A Hematzadeh","year":"2021","unstructured":"Hematzadeh A, Haghkhah M. Biotyping of isolates of Pseudomonas aeruginosa isolated from human infections by RAPD and ERIC-PCR. Heliyon. 2021. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07967.","journal-title":"Heliyon"},{"key":"4833_CR14","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1128\/9781555818814","volume-title":"Clinical microbiology procedures handbook","author":"AL Leber","year":"2016","unstructured":"Leber AL. Clinical microbiology procedures handbook. 4th ed. ASM Press; 2016. p. 2954. https:\/\/doi.org\/10.1128\/9781555818814.","edition":"4th ed"},{"key":"4833_CR15","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 34th ed. CLSI Supplement M100. Clinical and Laboratory Standards Institute, USA2024."},{"key":"4833_CR16","doi-asserted-by":"publisher","first-page":"1352483","DOI":"10.3389\/fimmu.2024.1352483","volume":"15","author":"P Sahoo","year":"2024","unstructured":"Sahoo P. Complementary supramolecular drug associates in perfecting the multidrug therapy against multidrug resistant bacteria. Front Immunol. 2024;15:1352483. https:\/\/doi.org\/10.3389\/fimmu.2024.1352483.","journal-title":"Front Immunol"},{"issue":"1","key":"4833_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/mdr.2006.12.39","volume":"12","author":"D Petropoulou","year":"2006","unstructured":"Petropoulou D, Tzanetou K, Syriopoulou VP, Daikos GL, Ganteris G, Malamou-Lada E. Evaluation of imipenem\/imipenem+ EDTA disk method for detection of metallo-\u03b2-lactamase-producing Klebsiella pneumoniae isolated from blood cultures. Microb Drug Resist. 2006;12(1):39\u201343. https:\/\/doi.org\/10.1089\/mdr.2006.12.39.","journal-title":"Microb Drug Resist"},{"issue":"10","key":"4833_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1089\/mdr.2024.0059","volume":"30","author":"W Ma","year":"2024","unstructured":"Ma W, Guo J, Deng C, Huang X, Sun Y, Xu L, et al. Characterization of the chromosomally located metallo-\u03b2-lactamase genes bla IMP-45 and bla VIM-2 in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate. Microb Drug Resist. 2024;30(10):422\u201331. https:\/\/doi.org\/10.1089\/mdr.2024.0059.","journal-title":"Microb Drug Resist"},{"issue":"10","key":"4833_CR19","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.22038\/IJBMS.2022.64359.14154","volume":"25","author":"M Seyedi","year":"2022","unstructured":"Seyedi M, Yousefi F, Naeimi B, Tajbakhsh S. Phenotypic and genotypic investigation of metallo-\u03b2-lactamases in Pseudomonas aeruginosa clinical isolates in Bushehr, Iran. Iran J Basic Med Sci. 2022;25(10):1196. https:\/\/doi.org\/10.22038\/IJBMS.2022.64359.14154.","journal-title":"Iran J Basic Med Sci"},{"key":"4833_CR20","doi-asserted-by":"publisher","unstructured":"Goudarzi H, Bostanghadiri N, Rad ZR, Rad ZR, Sharahi JY. Evaluation of \u03b2-lactamases and molecular typing of Pseudomonas aeruginosa clinical strains isolated from hospitalized children in Tehran, Iran. Arch Clin Infect Dis. 2023;18(18). https:\/\/doi.org\/10.5812\/archcid-134837","DOI":"10.5812\/archcid-134837"},{"key":"4833_CR21","doi-asserted-by":"crossref","unstructured":"Luengo A, Navarro Heredia L, Rabert C, Cort\u00e9s Cort\u00e9s PdC, Karahanian E, Corsini G. Development of a multiplex PCR assay for the detection of metallo-beta-lactamase genes in Pseudomonas aeruginosa. Int J Morphol. 2023;41(2):466\u201370. https:\/\/repositorio.udla.cl\/xmlui\/handle\/udla\/1524.","DOI":"10.4067\/S0717-95022023000200466"},{"issue":"1","key":"4833_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12941-021-00430-1","volume":"20","author":"E Jafari","year":"2021","unstructured":"Jafari E, Oloomi M, Bouzari S. Characterization of antimicrobial susceptibility, extended-spectrum \u03b2-lactamase genes and phylogenetic groups of Shigatoxin producing Escherichia coli isolated from patients with diarrhea in Iran. Ann Clin Microbiol Antimicrob. 2021;20(1):24. https:\/\/doi.org\/10.1186\/s12941-021-00430-1.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"7","key":"4833_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s10354-022-00970-x","volume":"173","author":"S Mamishi","year":"2023","unstructured":"Mamishi S, Akhlaghi A, Pourakbari B, Modaresi M, Haghi Ashtiani MT, Hosseinpour Sadeghi R, et al. Antimicrobial susceptibility and genotyping of microorganisms isolated from sputum culture of children with cystic fibrosis in an Iranian referral Children\u2019s Hospital. Wien Med Wochenschr. 2023;173(7):182\u20137. https:\/\/doi.org\/10.1007\/s10354-022-00970-x.","journal-title":"Wien Med Wochenschr"},{"key":"4833_CR24","doi-asserted-by":"publisher","first-page":"101152","DOI":"10.1016\/j.genrep.2021.101152","volume":"23","author":"ZR Rad","year":"2021","unstructured":"Rad ZR, Rad ZR, Goudarzi H, Goudarzi M, Alizade H, Hematian A, et al. Detection of New Delhi Metallo-\u03b2-lactamase-1 among Pseudomonas aeruginosa isolated from adult and Pediatric patients in Iranian hospitals. Gene Rep. 2021;23:101152. https:\/\/doi.org\/10.1016\/j.genrep.2021.101152.","journal-title":"Gene Rep"},{"key":"4833_CR25","doi-asserted-by":"publisher","unstructured":"Fu C, Lu J, Lu X, Feng Y, Zhang H, Tang W, Huang Q, Huang Y, Mo L, Huang H. Detection of Pseudomonas aeruginosa in 5,021 hospitalized pediatric patients presenting with acute respiratory tract infections utilizing targeted next-generation sequencing. Clinica Chimica Acta. 2025:120529. https:\/\/doi.org\/10.1016\/j.cca.2025.120529.","DOI":"10.1016\/j.cca.2025.120529"},{"issue":"1","key":"4833_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/fpd.2024.0066","volume":"22","author":"S Mahmoudi","year":"2025","unstructured":"Mahmoudi S, Jafari E, Pourakbari B, Poormohammadi S, Sadeghi RH, Mamishi S. Molecular epidemiology of carbapenemase-producing Pseudomonas aeruginosa: an Iranian referral hospital-based study. Foodborne Pathog Dis. 2025;22(1):51\u20137. https:\/\/doi.org\/10.1089\/fpd.2024.0066.","journal-title":"Foodborne Pathog Dis"},{"key":"4833_CR27","doi-asserted-by":"publisher","first-page":"105339","DOI":"10.1016\/j.micpath.2021.105339","volume":"162","author":"O Nassar","year":"2022","unstructured":"Nassar O, Desouky SE, El-Sherbiny GM, Abu-Elghait M. Correlation between phenotypic virulence traits and antibiotic resistance in Pseudomonas aeruginosa clinical isolates. Microb Pathog. 2022;162:105339. https:\/\/doi.org\/10.1016\/j.micpath.2021.105339.","journal-title":"Microb Pathog"},{"issue":"1","key":"4833_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00248-022-02095-5","volume":"86","author":"SP D\u00edaz-P\u00e9rez","year":"2023","unstructured":"D\u00edaz-P\u00e9rez SP, Solis CS, L\u00f3pez-Bucio JS, Valdez Alarcon JJ, Villegas J, la Reyes-De Cruz H, et al. Pathogenesis in Pseudomonas aeruginosa PAO1 biofilm-associated is dependent on the pyoverdine and pyocyanin siderophores by quorum sensing modulation. Microb Ecol. 2023;86(1):727\u201341. https:\/\/doi.org\/10.1007\/s00248-022-02095-5.","journal-title":"Microb Ecol"},{"issue":"4","key":"4833_CR29","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s15010-024-02313-x","volume":"52","author":"E Sendra","year":"2024","unstructured":"Sendra E, Fern\u00e1ndez-Mu\u00f1oz A, Zamorano L, Oliver A, Horcajada JP, Juan C, et al. Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective. Infection. 2024;52(4):1235\u201368. https:\/\/doi.org\/10.1007\/s15010-024-02313-x.","journal-title":"Infection"},{"issue":"4","key":"4833_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/tropicalmed8040205","volume":"8","author":"TA Hafiz","year":"2023","unstructured":"Hafiz TA, Bin Essa EA, Alharbi SR, Alyami AS, Alkudmani ZS, Mubaraki MA, et al. Epidemiological, microbiological, and clinical characteristics of multi-resistant Pseudomonas aeruginosa isolates in King Fahad Medical City, Riyadh, Saudi Arabia. Trop Med Infect Dis. 2023;8(4):205. https:\/\/doi.org\/10.3390\/tropicalmed8040205.","journal-title":"Trop Med Infect Dis"},{"issue":"6","key":"4833_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/antibiotics14060539","volume":"14","author":"RS Althaferi","year":"2025","unstructured":"Althaferi RS, Alfouzan WA, Mustafa AS. Antibiotics resistance profile of clinical isolates of Pseudomonas aeruginosa obtained from Farwaniya Hospital in Kuwait using phenotypic and molecular methods. Antibiotics. 2025;14(6):539. https:\/\/doi.org\/10.3390\/antibiotics14060539.","journal-title":"Antibiotics"},{"key":"4833_CR32","doi-asserted-by":"publisher","first-page":"1374466","DOI":"10.3389\/fmicb.2024.1374466","volume":"15","author":"A Elfadadny","year":"2024","unstructured":"Elfadadny A, Ragab RF, AlHarbi M, Badshah F, Ib\u00e1\u00f1ez-Arancibia E, Farag A, et al. Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Front Microbiol. 2024;15:1374466. https:\/\/doi.org\/10.3389\/fmicb.2024.1374466.","journal-title":"Front Microbiol"},{"key":"4833_CR33","doi-asserted-by":"publisher","first-page":"1280012","DOI":"10.3389\/fmicb.2023.1280012","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhu Y, Gao Y, Li W, Wang Y, Li Y. Evaluation and analysis of multidrug resistance-and hypervirulence-associated genes in carbapenem-resistant Pseudomonas aeruginosa strains among children in an area of China for five consecutive years. Front Microbiol. 2023;14:1280012. https:\/\/doi.org\/10.3389\/fmicb.2023.1280012.","journal-title":"Front Microbiol"},{"key":"4833_CR34","doi-asserted-by":"publisher","unstructured":"Parzen-Johnson S, Sun S, Scardina T, Patel SJ, editors. Fluoroquinolone use among hospitalized children: Diagnosis-based stratification to identify stewardship targets. Open Forum Infectious Diseases; 2023: Oxford University Press US. https:\/\/doi.org\/10.1093\/ofid\/ofad297","DOI":"10.1093\/ofid\/ofad297"},{"issue":"1","key":"4833_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13756-021-00936-5","volume":"10","author":"ST Ngoi","year":"2021","unstructured":"Ngoi ST, Chong CW, Ponnampalavanar SSLS, Tang SN, Idris N, Abdul Jabar K, et al. Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia. Antimicrob Resist Infect Control. 2021;10(1):70. https:\/\/doi.org\/10.1186\/s13756-021-00936-5.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"4833_CR36","doi-asserted-by":"publisher","first-page":"12932","DOI":"10.1038\/s41598-025-95950-7","volume":"15","author":"L Jin","year":"2025","unstructured":"Jin L, Ye H, Xu H, Shahzadi A, Pan X, Lou D. Genomic epidemiology and characterization of difficult-to-treat resistant Pseudomonas aeruginosa isolates co-harboring bla OXA-50 and crpP causing bronchiectasis. Sci Rep. 2025;15(1):12932. https:\/\/doi.org\/10.1038\/s41598-025-95950-7.","journal-title":"Sci Rep"},{"issue":"2","key":"4833_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/antibiotics13020159","volume":"13","author":"R Papa-Ezdra","year":"2024","unstructured":"Papa-Ezdra R, Outeda M, Cordeiro NF, Ara\u00fajo L, Gadea P, Garcia-Fulgueiras V, et al. Outbreak of Pseudomonas aeruginosa High-Risk Clone ST309 Serotype O11 Featuring bla PER-1 and qnrVC6. Antibiotics. 2024;13(2):159. https:\/\/doi.org\/10.3390\/antibiotics13020159.","journal-title":"Antibiotics"},{"issue":"1","key":"4833_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00438-025-02239-5","volume":"300","author":"KVM Xavier","year":"2025","unstructured":"Xavier KVM, de Oliveira Luz AC, Silva-Junior JW, de Melo BST, de Arag\u00e3o Batista MV, de Albuquerque Silva AM, et al. Molecular epidemiological study of Pseudomonas aeruginosa strains isolated from hospitals in Brazil by MLST and CRISPR\/Cas system analysis. Mol Genet Genomics. 2025;300(1):1\u201313. https:\/\/doi.org\/10.1007\/s00438-025-02239-5.","journal-title":"Mol Genet Genomics"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-04833-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:55:04Z","timestamp":1776164104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-04833-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-04833-y","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. The Ethics Committee of Tehran University of Medical Sciences approved the sampling protocols (IR.TUMS.CHMC.REC.1402.136), and written informed consent was secured from the parents or guardians of the patients before the data collection began.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}